Status
Conditions
Treatments
About
This study will evaluate subjective sleep over three consecutive menstrual cycles (menses and non-menses) in females reporting heavy menstrual bleeding. Following a baseline phase of one menstrual cycle, study subjects will use a standardized nighttime feminine product during menstruation for their second cycle. For the third cycle, subjects will continue to use the standardized menstrual product with behavioral modification that includes refraining from those sleep behaviors used to avoid nighttime menstrual leakage.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Women aged 18-50 years old
Generally healthy (self-assessed; no significant underlying disease)
Premenopausal patients with regular menstrual cycles every 21 to 35 days
Patients with at least 3 days and no more than 7 days of bleeding during menstruation
An intact uterus and at least one ovary
Ability and willingness to provide written informed consent
Willingness to adhere to study procedures
Menstrual pads are the primary form for nighttime menstrual protection needs
Will maintain a daily schedule that allows normal or typical sleep habits (ie, not a night-shift worker; >5 hours of sleep).
Women will self-report that they have heavy flow and perform at least one of the following compensatory behaviors:
Exclusion criteria
Currently pregnant or intending to imminently attempt pregnancy
Any condition (social or medical) that, in the opinion of the primary care giver or study staff, would make trial participation unsafe or complicate data interpretation
Difficult sleeping environment due to:
Use of an Intrauterine Device (IUDs) unless copper IUD.
Regular use (>1 day per week) of sleep aids and/or sedating medications, including over the counter products like melatonin.
Primary purpose
Allocation
Interventional model
Masking
25 participants in 1 patient group
Loading...
Central trial contact
Dermatology CTU
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal